A randomised controlled non-inferiority trial of primary care-based facilitated access to an alcohol reduction website (EFAR Spain): the study protocol.
Bottom Line: There is growing evidence that facilitated access by primary healthcare professionals (PHCPs) to a web-based BI can be a time-saving alternative to standard face-to-face BIs, but there is as yet no evidence about the effectiveness of this approach relative to conventional BI.Assuming reduction of 30% of risky drinkers receiving standard intervention, 1000 patients will be required to give 90% power to reject the hypothesis.The protocol was approved by the Ethics Commmittee of IDIAP Jordi Gol i Gurina P14/028.
Affiliation: GRAC, Addictions Unit, Department of Psychiatry, Clinical Institute of Neuroscience, Hospital Clínic, Fundació Clínic Recerca Biomèdica (FCRB), RETICS, University of Barcelona, Barcelona, Spain.Show MeSH
Related in: MedlinePlus
Mentions: Screening and Consent: Eligible patients will be given a trial brochure by their GP or nurse and actively encouraged to access the specially designed website ‘http://www.alcoholysalud.cat’. Each brochure will include a unique access number that will enable the patient to log on to the website. All patients who access the website will be informed about the trial and asked to complete an online form confirming that they do not meet any of the exclusion criteria and inviting them to complete the online consent module. They will then be asked to complete an online version of the short AUDIT-C.22 Cut-off points for the purpose of the trial will be 4 for women and 5 for men. Those screening negative will be informed that their responses indicated acceptable drinking patterns according to national guidelines and will be encouraged not to increase their alcohol consumption. Those scoring at or above the cut-off point will be invited by tailored online message from their PHCP to take part in the study as they present a risky drinking pattern (figure 1).
Affiliation: GRAC, Addictions Unit, Department of Psychiatry, Clinical Institute of Neuroscience, Hospital Clínic, Fundació Clínic Recerca Biomèdica (FCRB), RETICS, University of Barcelona, Barcelona, Spain.